BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C, Yuan Y, Robert L, Brunaud L, Bresler L. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg. 2010;200:435-439. [PMID: 20409524 DOI: 10.1016/j.amjsurg.2009.11.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Mulier S, Jiang Y, Jamart J, Wang C, Feng Y, Marchal G, Michel L, Ni Y. Bipolar radiofrequency ablation with 2 × 2 electrodes as a building block for matrix radiofrequency ablation: Ex vivo liver experiments and finite element method modelling. International Journal of Hyperthermia 2015;31:649-65. [DOI: 10.3109/02656736.2015.1046194] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
2 Zhou Y, Zhao L, Zhong X, Ding J, Zhou H, Wang F, Jing X. A thermochromic tissue-mimicking phantom model for verification of ablation plans in thermal ablation. Ann Transl Med 2021;9:354. [PMID: 33708981 DOI: 10.21037/atm-21-523] [Reference Citation Analysis]
3 Lin Y, Bale R, Brock KK, Odisio BC. Contemporary evidence on colorectal liver metastases ablation: toward a paradigm shift in locoregional treatment. International Journal of Hyperthermia 2022;39:649-63. [DOI: 10.1080/02656736.2021.1970245] [Reference Citation Analysis]
4 Kemeny N, Kurilova I, Li J, Camacho JC, Sofocleous CT. Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases. Cardiovasc Intervent Radiol 2019;42:1240-54. [DOI: 10.1007/s00270-019-02284-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Andersen IR, Thorup K, Jepsen BN, Mortensen FV, Nielsen DT, Rasmussen F. Dynamic contrast-enhanced computed tomography in the treatment evaluation of patients with colorectal liver metastases treated with ablation: a feasibility study. Acta Radiol 2019;60:936-45. [PMID: 30335477 DOI: 10.1177/0284185118806661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Li K, Su Z, Xu E, Huang Q, Zeng Q, Zheng R. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients. BMC Cancer 2017;17:61. [PMID: 28103837 DOI: 10.1186/s12885-017-3061-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
7 Lin YM, Paolucci I, Brock KK, Odisio BC. Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward. Cancers (Basel) 2021;13:3926. [PMID: 34439081 DOI: 10.3390/cancers13163926] [Reference Citation Analysis]
8 Mao R, Zhao JJ, Bi XY, Zhang YF, Han Y, Li ZY, Zhao H, Cai JQ. Resectable recurrent colorectal liver metastasis: can radiofrequency ablation replace repeated metastasectomy? ANZ J Surg 2019;89:908-13. [PMID: 31090189 DOI: 10.1111/ans.15080] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Liu M, Huang GL, Xu M, Pan FS, Lu MD, Zheng KG, Kuang M, Xie XY. Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy. Int J Hyperthermia 2017;33:446-53. [PMID: 28044471 DOI: 10.1080/02656736.2017.1278622] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
10 Rempp H, Hoffmann R, Roland J, Buck A, Kickhefel A, Claussen CD, Pereira PL, Schick F, Clasen S. Threshold-based prediction of the coagulation zone in sequential temperature mapping in MR-guided radiofrequency ablation of liver tumours. Eur Radiol. 2012;22:1091-1100. [PMID: 22105843 DOI: 10.1007/s00330-011-2335-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
11 Zhang K, Zou J, He K, Xu L, Liu P, Li W, Zhang A, Xu LX. Study of enhanced radiofrequency heating by pre-freezing tissue. Int J Hyperthermia 2018;35:79-89. [PMID: 29865914 DOI: 10.1080/02656736.2018.1476984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Collettini F, Schnapauff D, Poellinger A, Denecke T, Schott E, Berg T, Wust P, Hamm B, Gebauer B. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours. Eur Radiol 2012;22:1101-9. [PMID: 22173693 DOI: 10.1007/s00330-011-2352-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
13 Xu E, Lv S, Li K, Long Y, Zeng Q, Su Z, Zheng R. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. International Journal of Hyperthermia 2018;34:870-6. [DOI: 10.1080/02656736.2017.1373306] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
14 Santambrogio R, Barabino M, Bruno S, Costa M, Ceretti AP, Angiolini MR, Zuin M, Meloni F, Opocher E. Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients. Surg Endosc. 2015;Epub ahead of print. [PMID: 26275555 DOI: 10.1007/s00464-015-4468-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
15 Nieuwenhuizen S, Dijkstra M, Puijk RS, Timmer FEF, Nota IM, Opperman J, van den Bemd B, Geboers B, Ruarus AH, Schouten EAC, de Vries JJJ, Scheffer HJ, van Geel AM, van Waesberghe JHTM, Swijnenburg RJ, Versteeg KS, Lissenberg-Witte BI, van den Tol MP, Haasbeek CJA, Meijerink MR. Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry. Cancers (Basel) 2021;13:4303. [PMID: 34503113 DOI: 10.3390/cancers13174303] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Matsuki Y, Matono T, Koda M, Miyoshi K, Sugihara T, Okano JI, Isomoto H. Preablation three-dimensional ultrasonography can predict therapeutic effect and local tumor progression after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 2020;133:109358. [PMID: 33126170 DOI: 10.1016/j.ejrad.2020.109358] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Sindram D, Simo KA, Swan RZ, Razzaque S, Niemeyer DJ, Seshadri RM, Hanna E, McKillop IH, Iannitti DA, Martinie JB. Laparoscopic microwave ablation of human liver tumours using a novel three-dimensional magnetic guidance system. HPB (Oxford). 2015;17:87-93. [PMID: 25231167 DOI: 10.1111/hpb.12315] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
18 Tang K, Liu Y, Dong L, Zhang B, Wang L, Chen J, Chen G, Tang Z. Influence of thermal ablation of hepatic metastases from gastric adenocarcinoma on long-term survival: Systematic review and pooled analysis. Medicine (Baltimore) 2018;97:e13525. [PMID: 30544454 DOI: 10.1097/MD.0000000000013525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhang B, Moser MA, Luo Y, Zhang EM, Zhang W. Evaluation of the current radiofrequency ablation systems using axiomatic design theory. Proc Inst Mech Eng H 2014;228:397-408. [PMID: 24705341 DOI: 10.1177/0954411914530104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Nieuwenhuizen S, Dijkstra M, Puijk RS, Geboers B, Ruarus AH, Schouten EA, Nielsen K, de Vries JJJ, Bruynzeel AME, Scheffer HJ, van den Tol MP, Haasbeek CJA, Meijerink MR. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis. Curr Oncol Rep 2022. [PMID: 35298796 DOI: 10.1007/s11912-022-01248-6] [Reference Citation Analysis]
21 Poch FGM, Rieder C, Ballhausen H, Knappe V, Ritz JP, Gemeinhardt O, Kreis ME, Lehmann KS. Finding Optimal Ablation Parameters for Multipolar Radiofrequency Ablation. Surg Innov 2017;24:205-13. [PMID: 28193132 DOI: 10.1177/1553350617692492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
22 Chiang J, Hynes KA, Bedoya M, Brace CL. A dual-slot microwave antenna for more spherical ablation zones: ex vivo and in vivo validation. Radiology 2013;268:382-9. [PMID: 23579048 DOI: 10.1148/radiol.13122128] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
23 Chua JME, Lam YMP, Tan BS, Tay KH, Gogna A, Irani FG, Lo HGR, Too CW. Single-centre retrospective review of risk factors for local tumour progression and complications in radiofrequency ablation of 555 hepatic lesions. Singapore Med J 2019;60:188-92. [PMID: 31069400 DOI: 10.11622/smedj.2019036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Govaert KM, van Kessel CS, Lolkema M, Ruers TJ, Borel Rinkes IH. Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep. 2012;8:130-137. [PMID: 22611343 DOI: 10.1007/s11888-012-0122-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ye J, Huang G, Zhang X, Xu M, Zhou X, Lin M, Xie X, Xie X. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report. International Journal of Hyperthermia 2019;36:55-64. [DOI: 10.1080/02656736.2018.1530460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
26 Petre EN, Sofocleous C. Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease. Visc Med. 2017;33:62-68. [PMID: 28612019 DOI: 10.1159/000454697] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
27 Sucandy I, Cheek S, Golas BJ, Tsung A, Geller DA, Marsh JW. Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors. HPB (Oxford). 2016;18:756-763. [PMID: 27593593 DOI: 10.1016/j.hpb.2016.06.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
28 Sartori S, Tombesi P, Di Vece F. Thermal ablation in colorectal liver metastases: Lack of evidence or lack of capability to prove the evidence? World J Gastroenterol. 2016;22:3511-3515. [PMID: 27053843 DOI: 10.3748/wjg.v22.il3.3511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Naohara T, Aono H, Maehara T, Hirazawa H, Matsutomo S, Watanabe Y. Development of ti-coated ferromagnetic needle, adaptable for ablation cancer therapy by high-frequency induction heating. J Funct Biomater 2012;3:163-72. [PMID: 24956522 DOI: 10.3390/jfb3010163] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Wang X, Sofocleous CT, Erinjeri JP, Petre EN, Gonen M, Do KG, Brown KT, Covey AM, Brody LA, Alago W, Thornton RH, Kemeny NE, Solomon SB. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166-175. [PMID: 22535243 DOI: 10.1007/s00270-012-0377-1] [Cited by in Crossref: 160] [Cited by in F6Publishing: 159] [Article Influence: 16.0] [Reference Citation Analysis]
31 Mulier S, Jiang Y, Wang C, Jamart J, Marchal G, Michel L, Ni Y. Bipolar radiofrequency ablation with four electrodes: Ex vivo liver experiments and finite element method analysis. Influence of inter-electrode distance on coagulation size and geometry. International Journal of Hyperthermia 2012;28:686-97. [DOI: 10.3109/02656736.2012.706729] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
32 Yun D, Kim S, Song I, Chun K. Comparative analysis of Laparoscopic versus open surgical radiofrequency ablation for malignant liver tumors. Korean J Hepatobiliary Pancreat Surg 2014;18:122-8. [PMID: 26155264 DOI: 10.14701/kjhbps.2014.18.4.122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
33 Nielsen K, van Tilborg AA, Meijerink MR, Macintosh MO, Zonderhuis BM, de Lange ES, Comans EF, Meijer S, van den Tol MP. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg 2013;37:1340-7. [PMID: 23494086 DOI: 10.1007/s00268-013-1997-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
34 Wiggermann P, Puls R, Vasilj A, Sieroń D, Schreyer AG, Jung EM, Wawrzynek W, Stroszczynski C. Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival. Med Sci Monit 2012;18:CR88-92. [PMID: 22293882 DOI: 10.12659/msm.882463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
35 Wiggermann P, Jung E, Stroszczynski C. Radiofrequenzablation – ist eine Technik am Ende? Radiologe 2012;52:9-14. [DOI: 10.1007/s00117-011-2206-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Sartori S, Tombesi P, Di Vece F. Thermal ablation in colorectal liver metastases: Lack of evidence or lack of capability to prove the evidence? World J Gastroenterol 2016; 22(13): 3511-3515 [PMID: 27053843 DOI: 10.3748/wjg.v22.i13.3511] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Lai C, Jin RA, Liang X, Cai XJ. Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma. J Zhejiang Univ Sci B. 2016;17:236-246. [PMID: 26984844 DOI: 10.1631/jzus.b1500322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
38 Camacho JC, Petre EN, Sofocleous CT. Thermal Ablation of Metastatic Colon Cancer to the Liver. Semin Intervent Radiol 2019;36:310-8. [PMID: 31680722 DOI: 10.1055/s-0039-1698754] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
39 Ryan ER, Sofocleous CT, Schöder H, Carrasquillo JA, Nehmeh S, Larson SM, Thornton R, Siegelbaum RH, Erinjeri JP, Solomon SB. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology. 2013;268:288-295. [PMID: 23564714 DOI: 10.1148/radiol.13121462] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 8.2] [Reference Citation Analysis]
40 Jiang XY, Gu YK, Huang JH, Gao F, Zou RH, Zhang TQ. Ex Vivo Liver Experiment of Hydrochloric Acid-Infused and Saline-Infused Monopolar Radiofrequency Ablation: Better Outcomes in Temperature, Energy, and Coagulation. Cardiovasc Intervent Radiol 2016;39:600-5. [PMID: 26486153 DOI: 10.1007/s00270-015-1218-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Santambrogio R, Barabino M, De Nicola E, Galfrascoli E, Giovenzana M, Zappa MA. Laparoscopic ablation therapies for hepatocellular carcinoma: could specific indications for the laparoscopic approach influence the effectiveness? Updates Surg 2020;72:435-43. [DOI: 10.1007/s13304-020-00759-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, Li QY, Liu YM. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours. Eur Radiol 2015;25:1119-26. [PMID: 25407661 DOI: 10.1007/s00330-014-3483-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
43 Babawale SN, Jensen TM, Frøkjær JB. Long-term survival following radiofrequency ablation of colorectal liver metastases: A retrospective study. World J Gastrointest Surg 2015; 7(3): 33-38 [PMID: 25848490 DOI: 10.4240/wjgs.v7.i3.33] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
44 Poulou LS, Ziakas PD, Ziogas DC, Doxani C, Xyla V, Vakrinos G, Voulgarelis M, Thanos L. FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis. Biomarkers 2012;17:532-8. [DOI: 10.3109/1354750x.2012.699553] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
45 Lai Z, Liang J, Chen L, Wang Z, Ruan S, Xie X, Lu M, Hu H, Wang W. Do hepatocellular carcinomas located in subcapsular space or in proximity to vessels increase the rate of local tumor progression? A meta-analysis. Life Sciences 2018;207:381-5. [DOI: 10.1016/j.lfs.2018.06.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Huang J, Hernandez-Alejandro R, Croome KP, Zeng Y, Wu H, Chen Z. Hepatic resection for huge (>15 cm) multinodular HCC with macrovascular invasion. J Surg Res. 2012;178:743-750. [PMID: 22656039 DOI: 10.1016/j.jss.2012.04.058] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
47 Chiang J, Willey BJ, Del Rio AM, Hinshaw JL, Lee FT, Brace CL. Predictors of thrombosis in hepatic vasculature during microwave tumor ablation of an in vivo porcine model. J Vasc Interv Radiol 2014;25:1965-1971.e2. [PMID: 25255704 DOI: 10.1016/j.jvir.2014.07.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
48 Tsitskari M, Filippiadis D, Kostantos C, Palialexis K, Zavridis P, Kelekis N, Brountzos E. The role of interventional oncology in the treatment of colorectal cancer liver metastases. Ann Gastroenterol. 2019;32:147-155. [PMID: 30837787 DOI: 10.20524/aog.2019.0338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
49 Chiang J, Nickel K, Kimple RJ, Brace CL. Potential Mechanisms of Vascular Thrombosis after Microwave Ablation in an in Vivo Liver. J Vasc Interv Radiol 2017;28:1053-8. [PMID: 28456355 DOI: 10.1016/j.jvir.2017.03.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
50 Facciorusso A, Del Prete V, Muscatiello N, Crucinio N, Barone M. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation: Vitamin D and RFA for liver metastases. Journal of Gastroenterology and Hepatology 2016;31:1483-8. [DOI: 10.1111/jgh.13326] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
51 Tsitskari M, Filippiadis D, Kostantos C, Palialexis K, Zavridis P, Kelekis N, Brountzos E. The role of interventional oncology in the treatment of colorectal cancer liver metastases. Ann Gastroenterol. 2019;32:147-155. [PMID: 30837787 DOI: 10.20524/aog.2018.0338] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
52 Petre EN, Sofocleous CT, Solomon SB. Ablative and catheter-directed therapies for colorectal liver and lung metastases. Hematol Oncol Clin North Am 2015;29:117-33. [PMID: 25475575 DOI: 10.1016/j.hoc.2014.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
53 Long H, Zhuang B, Huang G, Li X, Lin M, Long J, Xie X, Liu B. Safety and Local Efficacy of Laser Ablation for the Extrahepatic Metastasis of Hepatocellular Carcinoma: An Available Treatment Strategy. Coatings 2020;10:951. [DOI: 10.3390/coatings10100951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Kim M, Kay CS, Jang WI, Kim MS, Lee DS, Jang HS. Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14-17). Medicine (Baltimore) 2017;96:e7202. [PMID: 28614265 DOI: 10.1097/MD.0000000000007202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]